Measles, mumps, and rubella vaccines
- PMID: 2407778
Measles, mumps, and rubella vaccines
Abstract
With widespread use of the live virus vaccines for measles, mumps, and rubella, there has been a dramatic decrease in the incidence of all three diseases. At the same time, an increasing proportion of the remaining cases are occurring in adolescents and adults. Thus, vaccinations for these three diseases of childhood must be included in a comprehensive program for adult immunization. The vaccines have a proven history of safety and efficacy and are usually administered together as combined measles-mumps-rubella (MMR) vaccine. Vaccination for measles, mumps, and rubella is particularly important for susceptible adults likely to come in contact with infected children. Adults at particularly high risk for exposure may include daycare center workers, teachers and other school employees, college students, medical personnel, and those planning to travel outside the United States.
Similar articles
-
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.N Engl J Med. 1994 Nov 24;331(21):1397-402. doi: 10.1056/NEJM199411243312101. N Engl J Med. 1994. PMID: 7969278
-
The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.Dev Biol Stand. 1986;65:45-52. Dev Biol Stand. 1986. PMID: 3104117 Review.
-
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. Schweiz Med Wochenschr. 1998. PMID: 9622837 German.
-
Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.Dev Biol Stand. 1986;65:37-43. Dev Biol Stand. 1986. PMID: 3556776
-
[Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].An Esp Pediatr. 1992 Apr;36(4):293-7. An Esp Pediatr. 1992. PMID: 1605414 Review. Spanish.
Cited by
-
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.Clin Diagn Lab Immunol. 2003 May;10(3):411-6. doi: 10.1128/cdli.10.3.411-416.2003. Clin Diagn Lab Immunol. 2003. PMID: 12738640 Free PMC article.
-
Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.Clin Vaccine Immunol. 2013 Nov;20(11):1719-28. doi: 10.1128/CVI.00533-13. Epub 2013 Sep 4. Clin Vaccine Immunol. 2013. PMID: 24006140 Free PMC article.
-
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.J Infect. 2004 Oct;49(3):179-209. doi: 10.1016/j.jinf.2004.05.018. J Infect. 2004. PMID: 15337336 Free PMC article. Review.
-
Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine.PLoS One. 2010 Aug 17;5(8):e12251. doi: 10.1371/journal.pone.0012251. PLoS One. 2010. PMID: 20808928 Free PMC article.
-
Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.Eur J Epidemiol. 1993 May;9(3):322-6. doi: 10.1007/BF00146271. Eur J Epidemiol. 1993. PMID: 8405319